COVID-19 & Cardiovascular Complications

The COVID-19 pandemic has significantly impacted cardiovascular health, leading to complications such as myocarditis, arrhythmias, and thromboembolic events. SARS-CoV-2 infection can trigger severe inflammation, endothelial dysfunction, and increased risk of heart failure, especially in high-risk patients. Long-term cardiovascular effects, including post-acute sequelae, remain a growing concern, requiring ongoing research and clinical management. Understanding these interactions is crucial for developing targeted therapies and improving patient outcomes.

 

    Related Conference of COVID-19 & Cardiovascular Complications

    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    April 27-28, 2027

    5th International Conference on World Heart Care

    Paris, France
    May 12-13, 2027

    42nd World Cardiology Conference

    London, UK
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    COVID-19 & Cardiovascular Complications Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in